Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The added value of PSMA PET/MR radiomics for prostate cancer staging.
Solari EL, Gafita A, Schachoff S, Bogdanović B, Villagrán Asiares A, Amiel T, Hui W, Rauscher I, Visvikis D, Maurer T, Schwamborn K, Mustafa M, Weber W, Navab N, Eiber M, Hatt M, Nekolla SG. Solari EL, et al. Among authors: eiber m. Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):527-538. doi: 10.1007/s00259-021-05430-z. Epub 2021 Jul 13. Eur J Nucl Med Mol Imaging. 2022. PMID: 34255130 Free PMC article.
Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer.
Beer AJ, Eiber M, Souvatzoglou M, Holzapfel K, Ganter C, Weirich G, Maurer T, Kübler H, Wester HJ, Gaa J, Krause BJ. Beer AJ, et al. Among authors: eiber m. Mol Imaging Biol. 2011 Apr;13(2):352-61. doi: 10.1007/s11307-010-0337-6. Mol Imaging Biol. 2011. PMID: 20490932
Radionuclide and hybrid imaging of recurrent prostate cancer.
Beer AJ, Eiber M, Souvatzoglou M, Schwaiger M, Krause BJ. Beer AJ, et al. Among authors: eiber m. Lancet Oncol. 2011 Feb;12(2):181-91. doi: 10.1016/S1470-2045(10)70103-0. Epub 2010 Jul 6. Lancet Oncol. 2011. PMID: 20599424 Review.
The sensitivity of [11C]choline PET/CT to localize prostate cancer depends on the tumor configuration.
Souvatzoglou M, Weirich G, Schwarzenboeck S, Maurer T, Schuster T, Bundschuh RA, Eiber M, Herrmann K, Kuebler H, Wester HJ, Hoefler H, Gschwend J, Schwaiger M, Treiber U, Krause BJ. Souvatzoglou M, et al. Among authors: eiber m. Clin Cancer Res. 2011 Jun 1;17(11):3751-9. doi: 10.1158/1078-0432.CCR-10-2093. Epub 2011 Apr 14. Clin Cancer Res. 2011. PMID: 21493868
Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions.
Eiber M, Martinez-Möller A, Souvatzoglou M, Holzapfel K, Pickhard A, Löffelbein D, Santi I, Rummeny EJ, Ziegler S, Schwaiger M, Nekolla SG, Beer AJ. Eiber M, et al. Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1691-701. doi: 10.1007/s00259-011-1842-9. Epub 2011 Jun 18. Eur J Nucl Med Mol Imaging. 2011. PMID: 21688050 Clinical Trial.
361 results